Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss

Brain

Volumn 118, Issue 6, 1995, Pages 1583-1592

  Davie, C A ^a   Barker, G J ^a   Webb, S ^a   Tofts, P S ^a   Thompson, A J ^a   Harding, A E ^a   Mcdonald, W I ^a   Miller, D H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Hereditary ataxia; MRS spectroscopy; Multiple sclerosis; N acetyl aspartate

Indexed keywords

CHOLINE DERIVATIVE; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL LOSS; CEREBELLAR ATAXIA; CEREBELLUM ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVE FIBER; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR FOSSA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

ADULT; AGED; ASPARTIC ACID; AXONS; CEREBELLAR ATAXIA; CEREBELLUM; GENES, DOMINANT; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 0029565567     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/118.6.1583     Document Type: Article

References (63)

1. Adams CWM, Poston RN, Buk SJ. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci 1989; 92: 291-306
2. Allen IV. Pathology of multiple sclerosis. In: Matthews WB, Compston A, Allen IV, Martyn CN, editors. McAlpine’s multiple sclerosis. 2nd ed. Edinburgh: Churchill Livingstone, 1991: 341-78
3. Arnold DL. Reversible reduction of N-acetylaspartate after acute central nervous system damage [abstract]. In: Proceedings of the Eleventh Annual Meeting of the Society for Magnetic Resonance in Medicine, 1992; 1: 643
4. Arnold DL, Matthews PM, Francis GS, O’Connor J, Antel JP. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 1992; 31: 235-41
5. Arnold DL, Riess GT, Matthews PM, Francis GS, Collins DL, Wolfson C, et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 1994; 36: 76-82
6. Barnes D, Munro PMG, Youl BD, Prineas JW, McDonald WI. The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain 1991; 114: 1271-80
7. Behar KL, Ogino T. Assignment of resonances in the 'H spectrum of rat brain by two-dimensional shift correlated and J-resolved NMR spectroscopy. Magn Reson Med 1991; 17: 285-303
8. Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 'H NMR spectroscopic studies of brain. [Review], Neurosci Biobehav Rev 1989; 13: 23-31
9. Black JA, Felts P, Smith KJ, Kocsis JD, Waxman SG. Distribution of sodium channels in chronically demyelinated spinal cord axons: immuno-ultrastructural localization and electophysiological observations. Brain Res 1991; 544: 59-70
10. Bolanos JP, Peuchen S, Heales SJR, Land JM, Clark JB. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J Neurochem 1994; 63: 910-16
11. Brenner RE, Munro PMG, Williams SCR, Bell JD, Barker GJ, Hawkins CP, et al. The proton NMR spectrum in acute EAE: the significance of the change in the cho:cr ratio. Magn Reson Med 1993a; 29: 737-15
12. Brenner RE, Munro PMG, Williams SCR, et al. Abnormal neuronal mitochondria: a cause of reduction in NA in demyelinating disease [abstract]. In: Proceedings of the Twelfth Annual Meeting of the Society for Magnetic Resonance in Medicine, 1993b; 1: 281
13. Casanova MF, Zito M, Weinberger DR, Kleinman JE. An immunocytochemical and autoradiographic study on the cellular localization of cholinergic markers in the human cerebellum [abstract]. Soc Neurosci Abstr 1990; 16: 535
14. Charcot M. Histologie de la sclérose en plaques. Gaz Hôsp 1868; 141: 554-5, 557-8
15. Christiansen P, Henriksen O, Stubgaard M, Gideon P, Larsson HBW. In vivo quantification of brain metabolites by 'H-MRS using water as an internal standard. Magn Reson Imaging 1993a; 11: 107-18
16. Christiansen P, Larsson HBW, Henriksen O. Time dependence of N-acetylaspartate and choline containing compounds in multiple sclerosis [abstract]. In: Proceedings of the Twelfth Annual Meeting of the Society for Magnetic Resonance in Medicine, 1993b; 1: 279
17. Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994a; 117: 49-58
18. Davie CA. Barker GJ, Brenton D, Miller DH, Thompson AJ. Proton magnetic resonance spectroscopy in adult cases of phenylketonuria [abstract], J Neurol Neurosurg Psychiatry 1994b; 57: 1292
19. Davie CA, Wenning GK, Barker GJ, Tofts PS, Kendall BE, Quinn N, et al. Differentiation of multiple system atrophy from idiopathic Parkinson’s disease using proton magnetic resonance spectroscopy. Ann Neurol 1995; 37; 204-10
20. Davies SEC, Newcombe J, Williams SR, McDonald WI, Clark JB. High resolution proton NMR spectroscopy of multiple sclerosis lesions. J Neurochem 1995; 64: 742-8
21. Dawson JW. The histology of disseminated sclerosis. Trans Roy Soc Edinb 1916; 50: 517-740
22. Feinstein A, Ron M, Thompson A. A serial study of psychometric and magnetic resonance imaging changes in multiple sclerosis. Brain 1993; 116: 569-602
23. Frahm J, Merboldt KD, Hänicke W. Localized proton spectroscopy using stimulated echoes. J Magn Reson 1987; 72: 502-8
24. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989a; 9: 79-93
25. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 1989b; II: 47-63
26. Frahm J, Michaelis T, Merboldt KD, Bruhn H, Gyngell ML, Hänicke W. Improvements in localized proton NMR spectroscopy of human brain. Water suppression, short echo times, and 1ml resolution. J Magn Reson 1990; 90: 464-73
27. Frisén L, Hoyt WF. Insidious atrophy of retinal nerve fibers in multiple sclerosis. Funduscopic identification in patients with and without visual complaints. Arch Ophthalmol 1974; 92: 91-7
28. Gass A, Barker GJ, Kidd D, Thorpe JW, MacManus D, Brennan A, et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994; 36: 62-7
29. Giunti P, Sweeney MG, Spadaro M, Jodice C, Novelletto A, Malaspina P, et al. The trinucleotide repeat expansion on chromosome 6p (SCA 1) in autosomal dominant cerebellar ataxias. Brain 1994; 117: 645-9
30. Grimaud J, Millar J, Thorpe JW, Moseley IF, McDonald WI. Signal intensity on MRI of basal ganglia in multiple sclerosis. J Neurol Neurosurg Psychiatry 1995; 59: 306-8
31. Halliday AM, McDonald WI, Mushin J. Delayed visual evoked response in optic neuritis. Lancet 1972; I: 982-5
32. Harding AE. The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of ‘the Drew family of Walworth.’ Brain 1982; 105: 1-28
33. Heales SJR, Davies SEC, Bates TE, Clark JB. Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochem Res 1995; 20: 31-8
34. Hoffman PM, Stuart WH, Earle KM, Brody JA. Hereditary late- onset cerebellar degeneration. Neurology 1971; 21: 771-7
35. Husted CA, Goodin DS, Hugg JW, Maudsley AA, Tsuruda JS, de Brie SH, et al. Biochemical alterations in multiple sclerosis lesions and normal appearing white matter detected by in vivo 3IP and 1H spectroscopic imaging. Ann Neurol 1994; 36: 157-65
36. Jenkins BG. Koroshetz WJ, Beal MF, Rosen BR. Evidence for impairment of energy metabolism in vivo in Huntington’s disease using localized 1H NMR spectroscopy. Neurology 1993; 43: 2689-95
37. Johnson AW, Land JM, Thompson, Bolanos JP, Clark JB, Heales SJR. Evidence for increased nitric oxide production in multiple sclerosis [letter]. J Neurol Neurosurg Psychiatry 1995; 58: 107
38. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, et al. CAG expansions in a novel gene for Machado- Joseph disease at chromosome 14q32.1 [see comments]. Nat Genet 1994; 8: 221-8
39. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, et al. Comment in: Nat Genet 1994; 8: 213-15
40. Kidd D, Thorpe JW, Thompson AJ, Kendall BE, Moseley IF, MacManus DG, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993; 43: 2632-7
41. Kish SJ, Currier RD, Shut L, Perry TL, Morito CL. Brain choline acetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy. Ann Neurol 1987; 22: 272-5
42. Kreiss R, Pietz J, Penzien J, Herschkowitz N, Boesch C. Unequivocal identification and quantitation of phenylalanine in the brain of patients with phenylketonuria by means of localised in vivo 'H MRS [abstract]. In: Proceedings of the second meeting of the Society of Magnetic Resonance, 1994; 1: 308
43. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52
44. Lassmann H, Suchanek G, Ozawa K. Histopathology and the blood- cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol 1994; 36 Suppl: S42-6
45. Malamud N. Neuropathology of phenylketonuria. J Neuropathol Exp Neurol 1966; 25: 254-68
46. McDonald WI, Miller DHM, Barnes D. The pathological evolution of multiple sclerosis. [Review], Neuropathol Appl Neurobiol 1992; 18: 319-34
47. Mcllwain H, Bachelard HS. Biochemistry and the central nervous system. Edinburgh: Churchill Livingstone, 1985: 282
48. Miller BL. A review of chemical issues in 'H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. [Review], NMR Biomed 1991; 4: 47-52
49. Miller DH, Austin SJ, Connelly A, Youl BD, Gadian DG, McDonald WI. Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis [letter] [see comments]. Lancet 1991; 337: 58-9
50. Miller DH, Austin SJ, Connelly A, Youl BD, Gadian DG, McDonald WI Comment in: Lancet 1991; 337: 362
51. Miller BL, Moats RA, Shonk T, Emst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased myo-inositol with proton MR spectroscopy. Radiology 1993; 187: 433-7
52. Mitrovic B, Ignarro LJ, Montestruque S, Smoll A, Merrill JE. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 1994; 61: 575-85
53. Moll C, Mourre C, Lazdunski M. Ulrich J. Increase of sodium channels in demyelinated lesions of multiple sclerosis. Brain Res 1991; 556: 311-16
54. Norton WT, Poduslo SE, Suzuki K. Subacute sclerosing leukoencephalitis. II. Chemical studies including abnormal myelin and an abnormal ganglioside pattern. J Neuropathol Exp Neurol 1966; 25: 582-97
55. Olanow CW. Magnetic resonance imaging in parkinsonism. [Review], Neurol Clin 1992; 10: 405-20
56. Ormerod IEC, Harding AE, Miller DH, Johnson G, MacManus D, du Boulay EPGH, et al. Magnetic resonance imaging in degenerative ataxic disorders. [Review], J Neurol Neurosurg Psychiatry 1994; 57: 51-7
57. Orr HT, Chung MY, Banfi S, Kwiatkowski TJ Jr, Servadio A, Beaudet AL, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993; 4: 221-6
58. Phadke JG, Best PV. Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. [Review], J Neurol Neurosurg Psychiatry 1983; 46: 414-20
59. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31
60. Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989; 39: 161-6
61. Schut JW, Haymaker W. Hereditary ataxia. A pathologic study of five cases of common ancestry. J Neuropath Clin Neurol 1951; 1: 183-213
62. Scolding NJ, Sussman J, Compston DAS. In vitro studies of oligodendrocytes derived from adult human white matter [abstract]. J Neurol 1994; 241 Suppl I: S27
63. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993; 13: 981-9